Abstract:
A method is provided for expressing a foreign gene, comprising the steps of: (a) producing a plant which functionally expresses an RNA1 genome and/or an RNA2 genome of Cucumber Mosaic Virus (CMV); (b) introducing a nucleic acid vector into the plant, said nucleic acid vector comprising, arranged in this order: (i) a right border sequence (RB) derived from the Agrobacterium T-DNA sequence; (ii) an expression promoter sequence workable in the plant; (iii) a sequence corresponding to an RNA3 genome of CMV in which a 3b gene, which codes for a 3b protein (coat protein), of CMV has been prevented from being expressed and the foreign gene has been inserted downstream of, and operably linked with, a subgenomic promoter which otherwise promotes the expression of the 3b gene; and (iv) a left border sequence (LB) derived from the Agrobacterium T-DNA sequence; and (c) culturing the plant containing the nucleic acid vector such that the RNA1 and/or RNA2 genome(s) of CMV is functionally expressed by the plant while the foreign gene is expressed transiently from the nucleic acid vector along with the CMV RNA3 genome lacking a region corresponding to the 3b gene.
Abstract:
It is an object of the present invention to provide a transmission-blocking vaccine using an immunogenic protein which is specifically expressed in the oocyst stage of malaria parasites or a peptide fragment thereof, and an oral transmission-blocking vaccine capable of immunizing various animals involved in the malaria infectious cycle with such a vaccine. The present invention relates to a malaria transmission-blocking vaccine for oral administration containing an immunogenic protein derived from malaria parasite which is specifically expressed in the oocyst stage of malaria parasites or a peptide fragment thereof, and a method of blocking the transmission of malaria using the same.
Abstract:
Plants are created with desired traits by conveniently and rapidly inhibiting methylation of target DNA in plants, without using recombination technology. Scaffold RNA produced by transcription of target DNA is cleaved in an RNA-directed DNA methylation mechanism.
Abstract:
The object of the present invention is to provide a therapeutic agent illustrating an immediate and sustained effect on chronic intractable external otitis. The present invention provide a composition, pharmaceutical composition, food and feed for preventing and/or treating chronic intractable external otitis, each comprising interferon-α (IFNα) as an active ingredient. Orally administering the composition of the present invention can provide inhibition, alleviation, treatment and prevention for chronic intractable external otitis. According to the present invention, IFNα can give a sufficient effect even when administered in a very small amount.
Abstract:
A nucleic acid molecule for expressing a foreign gene in a plant, said nucleic acid molecule carrying, in this order, a right border (RB) sequence derived from the T-DNA sequence of an agrobacterium, an expression promoter sequence capable of functioning in the aforesaid plant, a sequence corresponding to the RNA2 genome of cucumber mosaic virus wherein a 2b protein-encoding gene has been partly or entirely substituted by the aforesaid foreign gene, and a left border (LB) sequence derived from the T-DNA sequence of an agrobacterium.
Abstract:
It is an object of the present invention to provide a transmission-blocking vaccine using an immunogenic protein which is specifically expressed in the oocyst stage of malaria parasites or a peptide fragment thereof, and an oral transmission-blocking vaccine capable of immunizing various animals involved in the malaria infectious cycle with such a vaccine. The present invention relates to a malaria transmission-blocking vaccine for oral administration containing an immunogenic protein derived from malaria parasite which is specifically expressed in the oocyst stage of malaria parasites or a peptide fragment thereof, and a method of blocking the transmission of malaria using the same.
Abstract:
The object of the present invention is to provide a therapeutic agent illustrating an immediate and sustained effect on chronic intractable external otitis. The present invention provide a composition, pharmaceutical composition, food and feed for preventing and/or treating chronic intractable external otitis, each comprising interferon-α (IFNα) as an active ingredient. Orally administering the composition of the present invention can provide inhibition, alleviation, treatment and prevention for chronic intractable external otitis. According to the present invention, IFNα can give a sufficient effect even when administered in a very small amount.